[{"id":"6e52d59b-e044-4dc6-b5d9-453098a30db7","acronym":"","url":"https://clinicaltrials.gov/study/NCT06751251","created_at":"2025-02-26T08:08:56.521Z","updated_at":"2025-02-26T08:08:56.521Z","phase":"","brief_title":"The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination","source_id_and_acronym":"NCT06751251","lead_sponsor":"Peking University People's Hospital","biomarkers":" TNFRSF4","pipe":"","alterations":" ","tags":["TNFRSF4"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 200","initiation":"Initiation: 01/01/2025","start_date":" 01/01/2025","primary_txt":" Primary completion: 10/01/2025","primary_completion_date":" 10/01/2025","study_txt":" Completion: 10/01/2026","study_completion_date":" 10/01/2026","last_update_posted":"2024-12-27"}]